Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Buprenorphine
Sevodyne
Not routinely available
Local application
24/11/2021
Indication
In adults, for the treatment of chronic non-malignant pain of moderate intensity when an opioid is necessary for obtaining adequate analgesia. Restriction: for use in elderly patients (over 65 years).
Therapeutic Area
Central nervous system
Status Description
Not routinely available as local implementation plans are being developed or the ERFC is waiting for further advice from local clinical experts
Formulation
5, 10, 15 and 20 microgram/hour transdermal patch
Comments
November 2021 - Not routinely available as local implementation plans are being developed or the ADTC is waiting for further advice from local clinical experts – decision expected by 02 February 2022.